Trial intelligence / Profile preview

Inhaled Hypertonic Saline in Non-Cystic Fibrosis Bronchiectasis

NCT00484263Phase 3Completed

Sponsor
Alfred Health
Start
Dec 2007
Primary completion
Oct 2009
Modality
Small Molecules, Device-based Delivery
Countries
1
01

Overview

A Phase 3 trial of hypertonic saline in bronchiectasis, sponsored by Alfred Health. Started Dec 2007; status: completed.

02

Drugs

hypertonic saline
03

Conditions

bronchiectasis

Beyond the preview

Go deeper on NCT00484263.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00484263.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call